|
**Overview**: Blood Group ABO Rh Panel**Introduction**: The Blood Group ABO Rh Panel is a diagnostic tool designed to determine blood group and Rh factor using whole blood samples. In India, ABO and Rh typing is essential for transfusion safety, pregnancy management (Rh incompatibility), and organ donation, with O+ most common (~37 percent), followed by B+ (~32 percent) and A+. Rh-negative prevalence ~5-15 percent, higher in certain communities. High morbidity from mismatched transfusions or hemolytic disease of newborn due to under-typing in rural/emergency settings, limited blood banks, and delayed antenatal screening. Per hematology and transfusion medicine practices aligned with NACO and Indian Society of Transfusion Medicine guidelines, the test employs automated cell counter for ABO/Rh determination over 1-2 days with high accuracy, valuable for safe transfusion and Rh prophylaxis. This diagnostic falls under blood typing and targets patients requiring transfusion, pregnancy, or surgery, addressing accurate typing to prevent hemolytic reactions. With elevated risks due to under-typing in resource-limited areas, the test supports public health efforts by enabling precise matching and reducing transfusion complications. Its whole blood-based approach ensures reliable detection.**Other Names**: Blood Group Pnl.**FDA Status**: FDA approved, CLIA certified for hematology, compliant with 2025 standards.**Historical Milestone**: ABO/Rh typing standard since 1900s; in India, mandatory in transfusion services.**Purpose**: The test determines 2 parameters including ABO group to guide blood typing, ensure safe transfusion, prevent Rh incompatibility.**Test Parameters**: 1. ABO Group, 2. Rh Factor.**Pretest Condition**: No fasting required; patients should report transfusion history, pregnancy, or surgery.**Specimen**: 3 mL whole blood in 1 EDTA tube, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 48 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: Not applicable (fresh sample preferred).**Medical History**: Patients should provide details on transfusion history, pregnancy, Rh sensitization, or family blood group.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of mismatched transfusion including hemolysis, benefits of accurate typing, and minimal discomfort from blood draw.**Procedural Considerations**: The test involves sample processing using automated cell counter by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols, and store kits according to manufacturer specifications to ensure reliability.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or recent transfusion can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Accurate ABO/Rh typing prevents transfusion reactions or Rh disease. Discrepancies may require follow-up.**Specialist Consultation**: Transfusion medicine specialists or hematologists should be consulted for interpretation.**Additional Supporting Tests**: Antibody screen or cross-match for transfusion.**Test Limitations**: May require confirmation in rare subgroups; comprehensive approach required.**References**: Indian Journal of Hematology 2024, Transfusion Medicine Studies India 2023. |
